Trial Profile
A phase I trial to investigate DCB-0703 (LT-Flu vaccine) for the treatment of influenza virus infections
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs DCB 0703 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 30 Mar 2016 This trial was approved by the Taiwan FDA in March 2012, according to information on the company website.
- 30 Mar 2016 New trial record